On Friday, Moderna Inc (NASDAQ: MRNA) was 3.82% up from the session before settling in for the closing price of $34.30. A 52-week range for MRNA has been $29.25 – $170.47.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 662.63% over the past five years. When this article was written, the company’s average yearly earnings per share was at -8.83%. With a float of $341.55 million, this company’s outstanding shares have now reached $386.00 million.
Let’s look at the performance matrix of the company that is accounted for 5800 employees. In terms of profitability, gross margin is 52.28%, operating margin of -122.17%, and the pretax margin is -111.71%.
Moderna Inc (MRNA) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Moderna Inc stocks. The insider ownership of Moderna Inc is 11.47%, while institutional ownership is 70.76%. The most recent insider transaction that took place on Mar 03 ’25, was worth 5,004,318. In this transaction Chief Executive Officer of this company bought 160,314 shares at a rate of $31.22, taking the stock ownership to the 9,210,686 shares. Before that another transaction happened on Mar 03 ’25, when Company’s Director bought 31,620 for $31.76, making the entire transaction worth $1,004,251. This insider now owns 312,027 shares in total.
Moderna Inc (MRNA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -3.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -8.83% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.65% during the next five years compared to -42.94% drop over the previous five years of trading.
Moderna Inc (NASDAQ: MRNA) Trading Performance Indicators
You can see what Moderna Inc (MRNA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.28, a number that is poised to hit -3.11 in the next quarter and is forecasted to reach -7.80 in one year’s time.
Technical Analysis of Moderna Inc (MRNA)
Moderna Inc (NASDAQ: MRNA) saw its 5-day average volume 13.06 million, a positive change from its year-to-date volume of 12.69 million. As of the previous 9 days, the stock’s Stochastic %D was 80.80%. Additionally, its Average True Range was 2.72.
During the past 100 days, Moderna Inc’s (MRNA) raw stochastic average was set at 20.86%, which indicates a significant decrease from 73.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.63% in the past 14 days, which was higher than the 76.21% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $36.78, while its 200-day Moving Average is $72.83. Nevertheless, the first resistance level for the watch stands at $37.70 in the near term. At $39.80, the stock is likely to face the second major resistance level. The third major resistance level sits at $41.68. If the price goes on to break the first support level at $33.72, it is likely to go to the next support level at $31.84. Assuming the price breaks the second support level, the third support level stands at $29.74.
Moderna Inc (NASDAQ: MRNA) Key Stats
There are 385,816K outstanding shares of the company, which has a market capitalization of 13.74 billion. As of now, sales total 3,236 M while income totals -3,561 M. Its latest quarter income was 966,000 K while its last quarter net income were -1,120 M.
